Clinicopathological and prognostic significance of ubiquitin‐specific peptidase 15 and its relationship with transforming growth factor‐β receptors in patients with pancreatic ductal adenocarcinoma. Issue 2 (9th September 2020)
- Record Type:
- Journal Article
- Title:
- Clinicopathological and prognostic significance of ubiquitin‐specific peptidase 15 and its relationship with transforming growth factor‐β receptors in patients with pancreatic ductal adenocarcinoma. Issue 2 (9th September 2020)
- Main Title:
- Clinicopathological and prognostic significance of ubiquitin‐specific peptidase 15 and its relationship with transforming growth factor‐β receptors in patients with pancreatic ductal adenocarcinoma
- Authors:
- Jiang, Bolun
Zhou, Li
Lu, Jun
Wang, Yizhi
Liu, Chengxi
Liang, Zhiyong
Zhou, Weixun
You, Lei
Guo, Junchao - Other Names:
- Chiu Han‐Mo guestEditor.
- Abstract:
- Abstract: Background and Aim: Ubiquitin‐specific peptidase 15 (USP15) has been correlated to aggressive oncogenic behavior in several types of carcinomas, but its function in pancreatic ductal adenocarcinoma (PDAC) has not been clarified. This study aimed to evaluate the clinicopathological and prognostic value of USP15 and its relationship with transforming growth factor‐β (TGF‐β) receptors (TβRs) in PDAC. Methods: By immunohistochemical staining of tissue microarrays, the expression patterns of USP15 and TβRs were retrospectively analyzed in 287 PDAC patients who underwent radical surgical resection without neoadjuvant therapy. Cancer‐specific survival was compared based on USP15 expression, and the correlations between USP15 and TβRs were analyzed. Results: Ubiquitin‐specific peptidase 15 expression in tumor tissues was significantly higher than that in para‐tumor tissues ( P < 0.0001), and high USP15 expression was associated with the pathological N (pN) stage ( P = 0.033). In addition, high USP15 expression was significantly associated with shorter cancer‐specific survival ( P = 0.019). Univariate analyses showed that high USP15 expression ( P = 0.024), a poor histopathological grade ( P = 0.003), and the pN1 stage ( P = 0.009) were significantly correlated with shorter survival. Although the independent prognostic value of USP15 alone was not established, the combination of USP15 and the histological grade was identified as an independent prognostic factor inAbstract: Background and Aim: Ubiquitin‐specific peptidase 15 (USP15) has been correlated to aggressive oncogenic behavior in several types of carcinomas, but its function in pancreatic ductal adenocarcinoma (PDAC) has not been clarified. This study aimed to evaluate the clinicopathological and prognostic value of USP15 and its relationship with transforming growth factor‐β (TGF‐β) receptors (TβRs) in PDAC. Methods: By immunohistochemical staining of tissue microarrays, the expression patterns of USP15 and TβRs were retrospectively analyzed in 287 PDAC patients who underwent radical surgical resection without neoadjuvant therapy. Cancer‐specific survival was compared based on USP15 expression, and the correlations between USP15 and TβRs were analyzed. Results: Ubiquitin‐specific peptidase 15 expression in tumor tissues was significantly higher than that in para‐tumor tissues ( P < 0.0001), and high USP15 expression was associated with the pathological N (pN) stage ( P = 0.033). In addition, high USP15 expression was significantly associated with shorter cancer‐specific survival ( P = 0.019). Univariate analyses showed that high USP15 expression ( P = 0.024), a poor histopathological grade ( P = 0.003), and the pN1 stage ( P = 0.009) were significantly correlated with shorter survival. Although the independent prognostic value of USP15 alone was not established, the combination of USP15 and the histological grade was identified as an independent prognostic factor in multivariate analyses ( P = 0.015). USP15 expression was correlated with TβR‐I, TβR‐II, or TβR‐III expression in PDAC. Conclusions: High USP15 expression is a potential prognostic indicator in patients with PDAC, and it might affect the TGF‐β signaling pathway in PDAC. … (more)
- Is Part Of:
- Journal of gastroenterology and hepatology. Volume 36:Issue 2(2021)
- Journal:
- Journal of gastroenterology and hepatology
- Issue:
- Volume 36:Issue 2(2021)
- Issue Display:
- Volume 36, Issue 2 (2021)
- Year:
- 2021
- Volume:
- 36
- Issue:
- 2
- Issue Sort Value:
- 2021-0036-0002-0000
- Page Start:
- 507
- Page End:
- 515
- Publication Date:
- 2020-09-09
- Subjects:
- Immunohistochemistry -- Pancreatic ductal adenocarcinoma -- Prognosis -- Transforming growth factor β -- Ubiquitin‐specific peptidase 15
Gastroenterology -- Periodicals
Digestive organs -- Diseases -- Periodicals
Liver -- Diseases -- Periodicals
Gastroenterology -- Periodicals
Liver Diseases -- Periodicals
616.33 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1440-1746 ↗
http://onlinelibrary.wiley.com/ ↗
http://www.blackwell-synergy.com/loi/jgh ↗ - DOI:
- 10.1111/jgh.15244 ↗
- Languages:
- English
- ISSNs:
- 0815-9319
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4987.615000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 15876.xml